Immunohistochemical expression of JAG1, with respect to clinicopathological parameters, showed its association with the tumor vaginal involvement, Figo stage and lymph node metastasis, highlighting its clinical utility in ISCC. This evidence concerns the gene JAG1 and neoplasm.